PIM
QTTB icon

Platinum Investment Management’s Q32 Bio QTTB Stock Holding History

Platinum Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-66,801
Closed -$2.98M – 135
2024
Q3 		$2.98M Sell
66,801
-22,655
-25% -$832K 0.13% 58
2024
Q2 		$1.61M Sell
89,456
-20,508
-19% -$491K 0.07% 72
2024
Q1 		$1.87M Buy
+109,964
New +$1.52M 0.08% 72

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Platinum Investment Management's QTTB Position: Q4 2024 in Review

Platinum Investment Management sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 66,801 shares — an estimated $2.98M sold.

Platinum Investment Management first reported a position in QTTB in Q1 2024 and held it in 3 quarters. The position peaked at $2.98M in Q3 2024. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • Platinum Investment Management reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • Platinum Investment Management sold 66,801 Q32 Bio shares in Q4 2024, an estimated $2.98M.
  • Platinum Investment Management first reported a position in Q32 Bio in Q1 2024 and held it in 3 quarters.
  • Platinum Investment Management's Q32 Bio position peaked at $2.98M in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on Platinum Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.